Nordsjællands Hospital er en fællesbetegnelse, der dækker over tre nordsjællandske sygehuse i Region Hovedstaden. Den 1. februar 2013 blev Hillerød, Frederikssund og Helsingør Hospitaler samlet under navnet Nordsjællands Hospital.

During the past decade, Nordsjællands Hospital conducted 77 clinical trials. In the 10-year time frame, 77 clinical trials started and 13 clinical trials were completed, i.e. on average, 16.9% percent of trials that started reached the finish line to date. In the past 5 years, 49 clinical trials started and 8 clinical trials were completed. i.e. 16.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nordsjællands Hospital" #1 sponsor was "Nordsjaellands Hospital" with 23 trials, followed by "Rigshospitalet, Denmark" with 6 trials sponsored, "Bayer" with 4 trials sponsored, "Chronic Obstructive Pulmonary Disease Trial Network, Denmark" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 57 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nordsjællands Hospital" #1 collaborator was "Rigshospitalet, Denmark" with 11 trials as a collaborator, "Aarhus University Hospital" with 7 trials as a collaborator, "Copenhagen Trial Unit, Center for Clinical Intervention Research" with 7 trials as a collaborator, "Hvidovre University Hospital" with 6 trials as a collaborator and "University of Copenhagen" with 5 trials as a collaborator. Other collaborators include 83 different institutions and companies that were collaborators in the rest 69 trials.

According to Clinical.Site data, the most researched conditions in "Nordsjællands Hospital" are "Diabetes Mellitus, Type 1" (5 trials), "Breast Cancer" (3 trials), "COVID" (3 trials), "COVID-19" (3 trials) and "Covid-19" (3 trials). Many other conditions were trialed in "Nordsjællands Hospital" in a lesser frequency.

Most popular intervention types in "Nordsjællands Hospital" are "Drug" (45 trials), "Other" (24 trials), "Procedure" (11 trials), "Device" (10 trials) and "Behavioral" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Apixaban Oral Tablet" (2 trials), "Azithromycin" (2 trials), "Control" (2 trials) and "Dabigatran Etexilate Oral Capsule" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nordsjællands Hospital" are 93 trials for "All" genders, 8 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 33 active trials in "Nordsjællands Hospital". 2 are not yet recruiting, 21 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 50 completed trials in Nordsjællands Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Nordsjællands Hospital, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 21 trials, and there were also 29 trials that are defined as “Not Applicable".

Nordsjællands Hospital has several departments that took part in Clinical trials: "Nordsjællands Hospital, Hillerød, Onkologisk Afdeling" - 4 trials, "Hospitalerne i Nordsjælland Hillerød Hospital Ortopædkirurgisk afdeling" - 2 trials